|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
LEIRAS PHARMCEUTICAL HUTAMAKI OY
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Asthma |
|
Bronchospasm, exercise- induced |
| |
|
|
SIDE EFFECTS:
|
|
Palpitation |
|
tachycardia |
|
Adams-Stokes attacks |
|
allergic reactions |
|
angioedema |
|
bronchospasm |
|
oropharyngeal edema |
|
skin rash |
|
urticaria |
|
bronchospasm, paradoxical |
|
cardiac arrhythmias |
|
chest pain |
|
hypokalemia |
|
severe reaction |
|
erythema multiforme |
|
Stevens-Johnson syndrome |
|
hypertension |
|
psychoneurotic disorders |
|
psychomotor agitation |
|
disorientation |
|
impairment of memory |
|
assaultive behavior |
|
panic |
|
hallucinations |
|
suicidal or homicidal tendencies |
|
schizophrenic-type thought disorder |
|
paranoid delusions |
|
seizures |
|
urinary hesitation or retention |
|
Anxiety |
|
headache |
|
nervousness |
|
tremor |
|
Dizziness |
|
insomnia |
|
muscle cramps |
|
nausea |
|
sweating |
|
vertigo |
|
vomiting |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Cardiac arrhythmias |
|
>> Coronary insufficiency |
|
Hypertension, not optimally controlled |
|
Hyperthyroidism, not optimally controlled |
|
Pheochromocytoma, diagnosed or suspected |
|
>> Sensitivity to an adrenergic bronchodilator |
|
|
ADULT DOSE:
|
|
Bronchodilator-Oral inhalation, administered by nebulization, 2.5 mg (albuterol), delivered over approximately five to fifteen minutes, repeated every four to six hours. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Bronchodilator-Neonates and infants: Oral inhalation, administered by nebulization, 0.05 to 0.15 mg (albuterol) per kg of body weight delivered over approximately five to fifteen minutes, repeated every four to six hours.
Children up to 12 years of age: Oral inhalation, administered by nebulization, 1.25 to 2.5 mg delivered over approximately five to fifteen minutes, repeated every four to six hours if necessary.
Children 12 years of age and over: See Usual adult and adolescent dose. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|